Company - US
Type
Company
Country
🇺🇸 US
Ticker
Total Value
$61.67M
Apimeds Pharmaceuticals US is a biotech company developing non-opioid pain treatments, listed on NYSE American as APUS. In December 2025 it closed a $100 million private placement tied to its merger with MindWave Innovations, and about 1,000 BTC previously held by MindWave moved into a segregated structure meant to earn yield for the combined company.